Q2 25 EPS
$0.18
BEAT +3.39%
Est. $0.17
Q2 25 Revenue
$621.4M
BEAT +5.44%
Est. $589.4M
vs S&P Since Q2 25
-54.5%
TRAILING MARKET
CLVT -37.1% vs S&P +17.4%
Market Reaction
Did CLVT Beat Earnings? Q2 2025 Results
Clarivate delivered a clean beat to open the second half of 2025, with second-quarter adjusted diluted EPS of $0.18 edging past the $0.17 consensus by 3.39%, while revenue of $621.40 million topped estimates by 5.44%, even as headline sales slipped 4… Read more Clarivate delivered a clean beat to open the second half of 2025, with second-quarter adjusted diluted EPS of $0.18 edging past the $0.17 consensus by 3.39%, while revenue of $621.40 million topped estimates by 5.44%, even as headline sales slipped 4.4% year-over-year due to deliberate divestitures and product disposals rather than underlying weakness. The more meaningful story sits beneath the reported decline: organic revenues grew 0.5% and organic recurring revenues rose 0.8%, with the recurring mix improving to 88% for the first half of 2025, up 800 basis points from full-year 2024, reflecting the company's ongoing repositioning toward higher-quality subscription revenue. Academia & Government continued to lead with 2.5% organic growth in Q2 despite U.S. Government funding pressures, while the Intellectual Property segment returned to organic recurring revenue growth. Adjusted EBITDA margins held firm at 42.1%. Management reaffirmed full-year 2025 guidance, now expecting revenue toward the top end of the $2.28 billion to $2.40 billion range, with recurring organic growth trending into the upper half of the 1.0%-to-2.0% organic ACV target.
Key Takeaways
- • Organic subscription revenue growth of 1.7% driven by new sales and price increases
- • Organic ACV growth of 1.3% primarily driven by price increases
- • Improvement in recurring revenue mix to 88% of total organic revenue in H1 2025, up 800 bps from FY2024
- • Renewal rate improved to 93%, up 100 bps year-over-year
- • Strong cost management and discipline contributing to margin stability
- • A&G segment delivering 2.5% organic revenue growth in Q2
- • IP segment return to organic re-occurring revenue growth in H1 from patent annuity recovery
CLVT YoY Financials
Q2 2025 vs Q2 2024, source: SEC Filings
CLVT Revenue by Segment
With YoY comparisons, source: SEC Filings
“We reported solid second quarter performance and delivered growth in our key metrics. We have good momentum underway building off a solid first half of the year.”
— Matti Shem Tov, Q2 2025 Earnings Press Release
CLVT Earnings Trends
CLVT vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CLVT EPS Trend
Earnings per share: estimate vs actual
CLVT Revenue Trend
Quarterly revenue: estimate vs actual
CLVT Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $0.14 | $0.18 | +24.83% | $585.5M | +2.81% |
| Q4 25 BEAT FY | $0.16 | $0.20 | +22.25% | $617.0M | +2.02% |
| FY Full Year | $0.66 | $0.69 | +5.33% | $2.46B | +0.50% |
| Q3 25 BEAT | $0.16 | $0.18 | +15.09% | $623.1M | +9.25% |
| Q2 25 BEAT | $0.17 | $0.18 | +3.39% | $621.4M | +5.44% |
| Q1 25 BEAT | $0.12 | $0.14 | +20.69% | $593.7M | +4.09% |